Logotype for IGM Biosciences Inc

IGM Biosciences (IGMS) investor relations material

IGM Biosciences Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for IGM Biosciences Inc
Q2 2025 earnings summary31 Jul, 2025

Executive summary

  • Entered into a Merger Agreement with Concentra Biosciences, with closing expected in August 2025, subject to conditions including minimum net cash and shareholder tender.

  • Terminated all product development activities and closed all lab and office facilities following major restructurings in January and April 2025.

  • Sanofi collaboration agreement was fully terminated in June 2025, resulting in recognition of all remaining deferred revenue.

  • No current product candidates in development; future activities depend on outcome of the Merger.

Financial highlights

  • Net income of $97.6 million for Q2 2025, compared to a net loss of $47.9 million in Q2 2024, driven by non-cash revenue from Sanofi agreement termination.

  • Collaboration revenue of $143.6 million in Q2 2025, up from $1.3 million in Q2 2024, due to full recognition of deferred revenue.

  • Research and development expenses decreased to $5.9 million in Q2 2025 from $42.0 million in Q2 2024, reflecting program wind-downs and workforce reductions.

  • Impairment and disposal of long-lived assets charges of $31.9 million in Q2 2025, related to lease terminations and asset disposals.

  • Cash, cash equivalents, and marketable securities totaled $104.3 million as of June 30, 2025.

Outlook and guidance

  • Expenses and operating losses expected to decrease following restructuring and Sanofi agreement termination.

  • If the Merger is not completed, the board may pursue dissolution or liquidation.

  • No plans to develop new product candidates unless the Merger is not completed and a new strategy is adopted.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next IGM Biosciences earnings date

Logotype for IGM Biosciences Inc
Q3 20257 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next IGM Biosciences earnings date

Logotype for IGM Biosciences Inc
Q3 20257 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

IGM Biosciences Inc. is a clinical-stage biotechnology company focused on developing a new class of antibody medicines. Using the inherent advantages of the Immunoglobulin M (IgM) antibody structure, IGM Biosciences aims to create "super antibodies" for the treatment of cancer, as well as autoimmune and inflammatory diseases. By reimagining antibody medicines, the company believes it holds the world's most advanced research and development program for engineered therapeutic IgM antibodies. This approach seeks to expand upon and enhance the natural qualities of IgM antibodies, enabling the development of therapeutic antibodies designed to address a range of diseases more effectively. The company's pipeline includes multiple product candidates in various stages of clinical trials, targeting a variety of cancers and diseases through collaborations and license agreements to advance their research and potential treatments. IGM Biosciences is headquartered in Mountain View, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage